---
title: "TCT 2023: Five-year PARTNER 3 results “reaffirm” role of TAVI as alternative to surgery in low-risk patients"
date: "2023-10-25T18:01:26.000Z"
publishedDate: "25 octobre 2023"
summary: "Five-year data from the PARTNER 3 trial, which randomised low surgical risk aortic stenosis patients to receive either transcatheter aortic valve implantation (TAVI) with the Sapien 3 (Edwards Lifesciences) device or surgery, has continued to show equivalent performance between the two treatments against its composite endpoint of death, stroke or rehospitalisation. However, reporting the findings [&#8230;] The post TCT 2023: Five-year PARTNER 3 results “reaffirm” role of TAVI as alternative to surgery in low-risk patients appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/tct-2023-five-year-partner-3-results-reaffirm-role-of-tavi-as-alternative-to-surgery-in-low-risk-patients/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-10-25-tct-2023-five-year-partner-3-results-reaffirm-role-of-tavi-as-alternative-to-surgery-in-low-risk-patients"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/10/Marty-Leon-LBT.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/tct-2023-five-year-partner-3-results-reaffirm-role-of-tavi-as-alternative-to-surgery-in-low-risk-patients/"
---

![TCT 2023: Five-year PARTNER 3 results “reaffirm” role of TAVI as alternative to surgery in low-risk patients](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/10/Marty-Leon-LBT.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/tct-2023-five-year-partner-3-results-reaffirm-role-of-tavi-as-alternative-to-surgery-in-low-risk-patients/*

## L’essentiel

Five-year data from the PARTNER 3 trial, which randomised low surgical risk aortic stenosis patients to receive either transcatheter aortic valve implantation (TAVI) with the Sapien 3 (Edwards Lifesciences) device or surgery, has continued to show equivalent performance between the two treatments against its composite endpoint of death, stroke or rehospitalisation. However, reporting the findings [&#8230;] The post TCT 2023: Five-year PARTNER 3 results “reaffirm” role of TAVI as alternative to surgery in low-risk patients appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/tct-2023-five-year-partner-3-results-reaffirm-role-of-tavi-as-alternative-to-surgery-in-low-risk-patients/
